IMPLANT SITE FIBROSIS

This adverse event was reported 502 times

IMPLANT SITE FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETONOGESTREL 371 0.0064
1 HISTRELIN ACETATE 1 0.0011
2 BACLOFEN INJECTION 2 0.0006
3 ETONOGESTREL AND ETHINYL ESTRADIOL 12 0.0005
4 CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 1 0.0004
5 NORGESTIMATE AND ETHINYL ESTRADIOL 1 0.0002
6 ERGOCALCIFEROL 5 0.0002
7 NORTRIPTYLINE HYDROCHLORIDE 1 0.0002
8 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 1 0.0001
9 OXCARBAZEPINE 2 0.0001
See all drugs enriched for association with IMPLANT SITE FIBROSIS